Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

Skepticism About Mindray In America Overlooks Opportunities In China

The stock market is well past that period where almost anything China-related became an overnight sensation. That said, there are some powerful realities about the size of the Chinese economy and the opportunities in areas like healthcare. That brings us to the opportunity in Mindray Medical (NYSE:MR). Mindray is one of the very few Chinese med-tech companies to have a legitimate business outside of China, as well as extensive growth opportunities within China. Margins, domestic competition, and an uncertain strategy in the U.S. are all valid reasons for concern, but Mindray just may be one of the better growth opportunities in med-tech right now.

Fourth Quarter's Results Come In Pretty Solid

While Mindray had previously guided the Street...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details